The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| China Cord Blood Corp | Common | G21107100 | 153,452 | 15,437,800 | SH | DFND | 1, 2, 3 | 0 | 15,437,800 | 0 | |
| China Cord Blood Corp | Common | G21107900 | 444 | 528,500 | SH | Call | DFND | 1 | 0 | 528,500 | 0 |
| Alibaba Group Holding Limited | Common | 01609W952 | 563 | 155,000 | SH | Put | DFND | 1 | 0 | 155,000 | 0 |
| Baidu, Inc. | Common | 056751958 | 65 | 155,000 | SH | Put | DFND | 1 | 0 | 155,000 | 0 |